The company, which had posted a consolidated net profit of Rs 397.4 crore in the same quarter of the previous fiscal, mentioned its board has recommended a final dividend of Rs 6 per equity share of Re 1 each, subject to approval of shareholders at the Annual General Meeting scheduled to be held on August 11, 2023.
from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/y6MDHcn
Home »
Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com
» Zydus Lifesciences Q4 Results: Consolidated net profit dips 25 pc to Rs 297 crore
https://ift.tt/D0etRNs
No comments:
Post a Comment